l-glutathione ortho molecular G22010-25.0 - L-Glutathione, reduced, free

Female patients, smokers, gastric and mixed ulcer patients, patients with GERD or chronic diseases, subjects with chronic NSAIDs intake or regular intake of acid-inhibitory drugs, antibiotics or antioxidants in the preceding one month of the study

Mechanistically, the triple-agonist design is a deliberate departure from the GLP-1-monoagonist (liraglutide, semaglutide) and GIP/GLP-1-dual-agonist (tirzepatide) classes

Zhou J, An X, Dong J, Wang Y, Zhong H, Duan L

J Nutr Biochem (2014) 25(5):50314.10.1016/j.jnutbio.2013.10.012 68 SokolovAVAgeevaKVPulinaMOZakharovaETVasilyevVB

Funding We thank the Shandong Provincial Natural Science Foundation (ZR2021QB172), Key R&D Program of Shandong Province, China (2023CXPT012), Taishan Scholars Construction Engineering to GT (tstp20221145), National Natural Science Foundation of China (31771284), Taishan Scholars program to ZY (tsqn201812100), Shandong Provincial Natural Science Foundation (ZR2021MH292), Shandong Provincial Natural Science Foundation (ZR2021MH141), BZMC Scientific Research Foundation (BY2020KYQD08) for financial support of this study

NLRP3 at the interface of metabolism and inflammation